The search for biological approaches to PFAS destruction reflects a broader recognition that conventional treatment trains, while effective at separating these chemicals from water, do not actually break the extraordinarily strong carbon-fluorine bonds that make perfluorinated compounds so persistent. Adsorption onto granular activated carbon or anion exchange resins, and separation via reverse osmosis, merely concentrate PFAS into a smaller volume that must subsequently be incinerated or otherwise disposed of, raising concerns about cost, energy demand, and the potential for regenerating contaminated streams. Biological defluorination, if it could be harnessed reliably, would offer a fundamentally different proposition: the possibility of mineralizing these compounds under ambient temperatures and pressures, without the energy intensity of advanced oxidation or reductive electrochemical processes. The feammox pathway, in which Acidimicrobium sp. Strain A6 couples the oxidation of ammonium to the reduction of ferric iron, occupies a particularly interesting niche in this landscape because it simultaneously addresses two problems that often co-occur in impaired waters: excess ammonium, which complicates nitrogen removal in conventional treatment, and persistent fluorinated contaminants that resist aerobic biodegradation.

The chemistry underlying feammox helps explain why the choice of iron mineral matters so much. When goethite serves as the terminal electron acceptor, the overall reaction couples ammonium oxidation with ferric iron reduction, and the thermodynamics of that coupling depend on the specific crystalline form and surface area of the ferric phase present. Prior work has indicated that 6-line ferrihydrite, a poorly crystalline and highly reactive iron oxyhydroxide, supports greater A6 activity than goethite, a more crystalline and thermodynamically stable mineral. The research team nonetheless selected goethite for incorporation into their carriers, reasoning that ferrihydrite’s limited structural stability would make it poorly suited to embedding within a polymer matrix that must be manufactured at elevated temperatures and then deployed over long incubation periods. This trade-off between reactivity and durability is a recurring theme in the design of nutrient-integrated materials, and the modest activity observed in the incubations may partly reflect it: a goethite phase that survives melt-blending at 150 degrees Celsius may present less bioavailable ferric iron to the bacteria than the amorphous phases that support vigorous feammox in laboratory cultures.

The manufacturing approach itself deserves attention as a contribution to the growing field of engineered biofilm supports. Melt-blending polyethylene, polyethylene oxide, zeolite, and goethite at 150 degrees Celsius, followed by hot pressing into thin sheets and punching into uniform discs, produces carriers that can in principle be fabricated at scale using conventional polymer processing equipment. The subsequent water etching step, in which the water-soluble polyethylene oxide fraction is dissolved away over 48 hours, leaves behind a porous architecture whose void spaces were once occupied by PEO. This sacrificial-porogen strategy is well established in materials science and offers a route to controlled porosity without the need for harsh chemical etchants. Zeolite, an aluminosilicate with well-characterized cation exchange properties, serves as the ammonium reservoir within the composite, while the polyethylene backbone provides the mechanical integrity needed for the carriers to persist in a reactor environment without disintegrating. The demonstration that iron-enhanced carriers sorbed more ammonium than carriers lacking goethite suggests that the mineral addition did not simply dilute the zeolite but may have contributed additional surface area or exchange capacity, an encouraging sign for the carrier concept even before biological testing began.

The experimental design, with four distinct culture environments compared in batch incubations spiked with 10 milligrams per liter of PFOA and monitored over roughly 100 days, reflects the realities of working with an organism as slow-growing and fastidious as A6. Batch systems, while simple to operate and interpret, impose constraints that continuous or fed-batch systems do not: nutrients are finite, metabolic byproducts accumulate, and there is no opportunity to replenish the ammonium that feammox consumes or the ferric iron that is progressively reduced to ferrous iron as the reaction proceeds. Over a 100-day incubation, the localized stores of ammonium and ferric iron within the carriers would be the primary nutrient sources available to bacteria residing on or near the carrier surface, which is precisely the design intent, but it also means that any depletion of those stores would go uncorrected. The absence of measurable PFOA removal, even in the positive control incubations, complicates interpretation of the carrier performance specifically, since it suggests that conditions across all treatments were unfavorable for feammox activity, not merely that the carriers failed to deliver their intended nutrients.

The detection of A6 on the carriers at the end of the incubations, at roughly a thousand gene copies per carrier, is among the more informative findings of the study. It indicates that the porous polyethylene-zeolite matrix is not toxic to the organism and can retain it through repeated sampling and extended incubation, a prerequisite for any carrier-based deployment. Retention without measurable activity, however, points to a gap between survival and function that future work must close. Several candidate explanations merit consideration. Low initial cell concentrations mean that even modest absolute growth could be difficult to distinguish from background noise in quantitative polymerase chain reaction measurements, and slow-growing organisms may require longer than 100 days to build the biomass needed for detectable transformation of a substrate as recalcitrant as PFOA. The iron phase question, discussed above, remains open, as does the possibility that other organisms in the enrichment cultures outcompeted A6 for ammonium or other resources, since the incubations used enrichment cultures rather than pure strains and total bacterial numbers were monitored alongside A6 specifically.

The broader literature on PFAS biotransformation provides useful context for calibrating expectations. The meta-analysis cited in the study, covering 97 publications from 1989 through 2023, found that while a majority of aerobic experiments documented some biotransformation of fluorinated compounds, evidence of actual fluoride release, the definitive signature of defluorination, appeared in a substantially smaller fraction of cases. Anaerobic experiments, though fewer in number and longer in duration on average, showed a similar pattern. Fully saturated perfluorinated carbons such as those in PFOA and PFOS are the most resistant to enzymatic attack, and the compounds that have yielded most readily to biological transformation tend to be shorter-chain or contain unsaturated bonds that offer a chemical foothold for reductive enzymes. The reductive dehalogenase genes identified in feammox cultures, including rdhA, which encodes the catalytically active subunit and was expressed at higher levels in the presence of PFAS, suggest a plausible enzymatic mechanism, but gene presence and even elevated expression do not guarantee that transformation proceeds at rates meaningful for engineering purposes.

Looking forward, several parameters identified in this study would be natural targets for optimization. Increasing the initial A6 inoculum would shorten the time needed to reach cell densities at which transformation becomes detectable. Exploring iron phases that balance bioavailability with manufacturability, perhaps by incorporating ferrihydrite in a protected form or by post-synthetic mineral deposition onto the finished carriers, could address the reactivity-durability trade-off. Operating in continuous or semi-continuous mode with periodic nutrient replenishment would prevent the depletion of ammonium and ferric iron that likely constrains batch incubations. Controlling the microbial community composition, whether through selective enrichment protocols or by starting from more defined consortia, would reduce the uncertainty introduced by competitors. And extending incubation durations beyond 100 days, informed by the meta-analytic finding that anaerobic PFAS experiments average roughly 90 days with substantial variability, would give slow-growing organisms a fairer opportunity to demonstrate activity. None of these adjustments guarantees success, but together they define a clearer experimental path than the one this first-generation carrier evaluation could follow.

It is also worth situating this work within the engineering challenge of PFAS treatment at scale. Even if feammox-based defluorination is eventually demonstrated at meaningful rates, the concentrations at which PFAS typically occur in contaminated waters, often in the nanogram to low microgram per liter range, are far below the 10 milligrams per liter used in these incubations, which was chosen to facilitate analytical detection. Bridging that gap will require either concentrating PFAS prior to biological treatment or achieving transformation at environmentally relevant concentrations, both of which impose additional design constraints. Carrier-based systems, by localizing biomass and nutrients, could in principle be integrated into packed-bed or fluidized-bed reactor configurations that concentrate both the organism and the contaminant, but that vision depends on first establishing reliable, reproducible feammox activity under controlled conditions. This study’s contribution lies less in demonstrating that vision than in mapping, with unusual candor, the specific obstacles that stand between the current state of the art and its realization: the iron phase, the inoculum density, the competitive microbial ecology, and the sheer patience that anaerobic defluorination research demands.

The interdisciplinary character of the effort is itself noteworthy. Bringing together environmental engineers, a geochemist, and a polymer chemist reflects the reality that solutions to PFAS contamination will not emerge from any single discipline. The synthesis of a functional composite material, the characterization of its sorption behavior, the cultivation of a fastidious anaerobe, and the analytical chemistry of tracking PFOA and fluoride over months of incubation each demand distinct expertise, and the integration of these strands into a single experimental platform is a nontrivial achievement regardless of the biological outcome. Negative results of this kind, when they are well-controlled and carefully interpreted, can redirect subsequent research more efficiently than incremental positive results, and the identification of carrier retention of A6 as a demonstrated capability, alongside the enumeration of the specific factors limiting activity, provides a foundation on which the next iteration of carrier design can build.

Subject of Research: …

Article Title: Evaluation of porous polyethylene-supported zeolite carriers to support feammox-based perfluorooctanoic acid biotransformation

Article References: Evaluation of porous polyethylene-supported zeolite carriers to support feammox-based perfluorooctanoic acid biotransformation. (n.d.). https://doi.org/10.3389/fenve.2026.1878655

Image Credits: AI Generated

DOI: 10.3389/fenve.2026.1878655

Keywords: PFAS, PFOA, feammox, Acidimicrobium strain A6, zeolite carriers, polyethylene support, bioremediation, iron reduction, ammonium oxidation, anaerobic biotransformation, defluorination, water treatment